Published in AIDS Weekly, March 22nd, 2010
"Using a dog model, we determined point estimates for C-max and AUC of ritonavir and lopinavir/ritonavir for eight generic products compared to Abbott's Norvir ® capsule and Kaletra ® tablet. Chemical potencies ranged from 79.0% to 104.6%. Point estimates for AUC in the generic tablet products...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.